Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
5.76%
↓ 87% below average
Average (39q)
44.73%
Historical baseline
Range
High:682.86%
Low:-52.75%
Volatility
1644.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 5.76% |
| Q2 2025 | 48.31% |
| Q1 2025 | -21.82% |
| Q4 2024 | 25.80% |
| Q3 2024 | 14.35% |
| Q2 2024 | 11.98% |
| Q1 2024 | 7.15% |
| Q4 2023 | 7.69% |
| Q3 2023 | 17.08% |
| Q2 2023 | 67.59% |
| Q1 2023 | 30.48% |
| Q4 2022 | 105.18% |
| Q3 2022 | -52.75% |
| Q2 2022 | 505.21% |
| Q1 2022 | -17.56% |
| Q4 2021 | 76.75% |
| Q3 2021 | 275.18% |
| Q2 2021 | 682.86% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |